Screener
Cogent Biosciences, Inc. COGT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Weighted average Series A non-voting convertible preferred stock outstanding, basic and diluted | 39,414 | 67,686 | 53,337 | 67,788 |
| Net loss per share, basic and diluted, Series B non-voting convertible preferred stock | $(520.15) | $(531.89) | $(1,050.27) | $(1,052.27) |
| Weighted average Series B non-voting convertible preferred stock outstanding, basic and diluted | 4,516 | 6,868 | 4,516 | 6,868 |
| Net loss per share, basic and diluted, common stock | $(0.52) | $(0.53) | $(1.05) | $(1.05) |
| Weighted average common stock outstanding, basic and diluted | 171,005,468 | 114,466,080 | 166,624,462 | 114,463,810 |
| Comprehensive loss: | ||||
| Net loss | $(96,405) | $(73,529) | $(193,757) | $(145,515) |
| Other comprehensive income (loss): |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s EPS (diluted)?
- Cogent Biosciences, Inc. (COGT) reported EPS (diluted) of -$0.52 in Q2 2026.
- How has Cogent Biosciences, Inc.'s EPS (diluted) changed year-over-year?
- Cogent Biosciences, Inc.'s EPS (diluted) increased by 1.9% year-over-year, from -$0.53 to -$0.52.
- What is the long-term trend for Cogent Biosciences, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s EPS (diluted) has grown at a 3.7% compound annual growth rate (CAGR), from -$1.87 to -$2.16.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Cogent Biosciences, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude